Paul Mcbarron - Net Worth and Insider Trading
Paul Mcbarron Net Worth
The estimated net worth of Paul Mcbarron is at least $11,515 dollars as of 2024-11-29. Paul Mcbarron is the See Remarks of Cyclacel Pharmaceuticals Inc and owns about 33,378 shares of Cyclacel Pharmaceuticals Inc (CYCC) stock worth over $11,515. Details can be seen in Paul Mcbarron's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Mcbarron has not made any transactions after 2023-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Mcbarron
Paul Mcbarron Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Mcbarron owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of Paul Mcbarron’s form 4 insider trades.
Insider Ownership Summary of Paul Mcbarron
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2023-12-21 | director & E.V.P. & Finance & C.O.O. |
Paul Mcbarron Latest Holdings Summary
Paul Mcbarron currently owns a total of 1 stock. Paul Mcbarron owns 33,378 shares of Cyclacel Pharmaceuticals Inc (CYCC) as of December 21, 2023, with a value of $11,515.
Latest Holdings of Paul Mcbarron
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCC | Cyclacel Pharmaceuticals Inc | 2023-12-21 | 33,378 | 0.35 | 11,515 |
Holding Weightings of Paul Mcbarron
Paul Mcbarron Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Mcbarron has made a total of 1 transactions in Cyclacel Pharmaceuticals Inc (CYCC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cyclacel Pharmaceuticals Inc is the acquisition of 1,886 shares on December 21, 2023, which cost Paul Mcbarron around $6,262.
Insider Trading History of Paul Mcbarron
- 1
Paul Mcbarron Trading Performance
GuruFocus tracks the stock performance after each of Paul Mcbarron's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Mcbarron is -23.14%. GuruFocus also compares Paul Mcbarron's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Mcbarron within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Mcbarron's insider trading performs compared to the benchmark.
Performance of Paul Mcbarron
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22 | | | | | |
| Relative Return to S&P 500(%) | -20.68 | | | | | |
Paul Mcbarron Ownership Network
Paul Mcbarron Owned Company Details
What does Cyclacel Pharmaceuticals Inc do?
Who are the key executives at Cyclacel Pharmaceuticals Inc?
Paul Mcbarron is the director & E.V.P. & Finance & C.O.O. of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , Chief Medical Officer Mark Kirschbaum , and 10 percent owner Eastern Capital Ltd .
Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary
Over the past 18 months, Paul Mcbarron made 1 insider transaction in Cyclacel Pharmaceuticals Inc (CYCC) with a net purchase of 1,886. Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.
Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclacel Pharmaceuticals Inc Insider Transactions
Paul Mcbarron Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Mcbarron. You might contact Paul Mcbarron via mailing address: C/o Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite 1500, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
